eedq has been researched along with rx 821002 in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (71.43) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goiny, M; Herrera-Marschitz, M; Meana, JJ | 1 |
| Durcan, MJ; Linnoila, M; Morgan, PF; Van Etten, ML | 1 |
| García-Sevilla, JA; Miralles, A; Ribas, C | 1 |
| García-Sevilla, JA; Miralles, A; Olmos, G; Ribas, C | 1 |
| Escribá, PV; García-Sevilla, JA; Miralles, A; Ribas, C | 1 |
| Busquets, X; García-Sevilla, JA; Miralles, A; Ribas, C | 1 |
| Alba-Delgado, C; Berrocoso, E; Llorca-Torralba, M; Mico, JA; Torres-Sanchez, S | 1 |
7 other study(ies) available for eedq and rx 821002
| Article | Year |
|---|---|
In vivo modulation of norepinephrine and glutamate release through imidazoline receptors in the rat central nervous system.
Topics: Adrenergic alpha-2 Receptor Antagonists; Animals; Central Nervous System; Clonidine; Dioxanes; Glutamic Acid; Idazoxan; Imidazoline Receptors; Norepinephrine; Quinolines; Rats; Receptors, Drug | 1995 |
Covariation of alpha 2-adrenoceptor density and function following irreversible antagonism with EEDQ.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Body Temperature; Dioxanes; Drug Interactions; Exploratory Behavior; Hypnotics and Sedatives; Idazoxan; Imidazoles; Male; Medetomidine; Mice; Motor Activity; Quinolines; Radioligand Assay; Receptors, Adrenergic, alpha-2 | 1994 |
Acceleration by chronic treatment with clorgyline of the turnover of brain alpha 2-adrenoceptors in normotensive but not in spontaneously hypertensive rats.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Brain Chemistry; Brimonidine Tartrate; Cerebral Cortex; Clorgyline; Dioxanes; Down-Regulation; Hypertension; Idazoxan; In Vitro Techniques; Kinetics; Male; Membranes; Quinolines; Quinoxalines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Species Specificity | 1993 |
Differential effects of the alkylating agent N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on brain alpha 2-adrenoceptors and I2-imidazoline sites in vitro and in vivo.
Topics: Animals; Binding Sites; Brain; Cell Membrane; Dioxanes; Idazoxan; Imidazoles; Isoenzymes; Kinetics; Male; Monoamine Oxidase; Neurons; Picolinic Acids; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Thermodynamics; Thiazoles; Tritium | 1993 |
Effects of the alkylating agent EEDQ on regulatory G proteins and recovery of agonist and antagonist alpha2-adrenoceptor binding sites in rat brain.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Alkylating Agents; Animals; Brimonidine Tartrate; Cerebral Cortex; GTP-Binding Proteins; Idazoxan; Male; Quinolines; Quinoxalines; Rats; Rats, Sprague-Dawley | 1998 |
Brain alpha(2)-adrenoceptors in monoamine-depleted rats: increased receptor density, G coupling proteins, receptor turnover and receptor mRNA.
Topics: Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Animals; Binding, Competitive; Brain; Brimonidine Tartrate; Clonidine; Dose-Response Relationship, Drug; Epinephrine; Gene Expression Regulation; GTP-Binding Proteins; Idazoxan; Male; Membranes; Norepinephrine; Quinolines; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Reserpine; RNA, Messenger; Tritium | 2001 |
Effect of tapentadol on neurons in the locus coeruleus.
Topics: Action Potentials; Adrenergic alpha-2 Receptor Antagonists; Analgesics, Opioid; Analysis of Variance; Animals; Dose-Response Relationship, Drug; Drug Interactions; Idazoxan; Locus Coeruleus; Male; Narcotic Antagonists; Neural Inhibition; Neurons; Phenols; Quinolines; Rats; Rats, Sprague-Dawley; Tapentadol | 2013 |